Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review

L Cho, M Davis, I Elgendy, K Epps, KJ Lindley… - Journal of the American …, 2020 - jacc.org
Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality for
women in the United States and worldwide. There has been no American College of …

Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey

R Kones - Drug design, development and therapy, 2011 - Taylor & Francis
A recent explosion in the amount of cardiovascular risk and incipient, undetected subclinical
cardiovascular pathology has swept across the globe. Nearly 70% of adult Americans are …

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology …

NJ Stone, JG Robinson, AH Lichtenstein… - Circulation, 2014 - Am Heart Assoc
The Blood Cholesterol Expert Panel (Expert Panel) was originally convened as the Expert
Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult …

[HTML][HTML] National Lipid Association recommendations for patient-centered management of dyslipidemia: part 2

TA Jacobson, KC Maki, CE Orringer, PH Jones… - Journal of clinical …, 2015 - Elsevier
Abstract An Expert Panel convened by the National Lipid Association previously developed
a consensus set of recommendations for the patient-centered management of dyslipidemia …

Statins in the primary prevention of cardiovascular disease

Ž Reiner - Nature Reviews Cardiology, 2013 - nature.com
Statins are widely used in the evidence-based lowering of cardiovascular disease (CVD)
risk. The use of these drugs for secondary prevention of CVD is well founded, but their …

Primary prevention of atherosclerosis: a clinical challenge for the reversal of epigenetic mechanisms?

C Napoli, V Crudele, A Soricelli, M Al-Omran, N Vitale… - Circulation, 2012 - Am Heart Assoc
Although elevated levels of serum low-density lipoprotein cholesterol (LDL-C) are the major
cause of onset of the disease, as established by a large number of superb epidemiological …

Drugs for primary prevention of atherosclerotic cardiovascular disease: an overview of systematic reviews

KN Karmali, DM Lloyd-Jones, MA Berendsen… - JAMA …, 2016 - jamanetwork.com
Importance The Million Hearts initiative emphasizes ABCS (aspirin for high-risk patients,
blood pressure [BP] control, cholesterol level management, andsmoking cessation) …

[PDF][PDF] An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia–full report Expert Dyslipidemia Panel of …

H Arai, MH Davidson, A Kesaniemi… - Journal of clinical …, 2014 - Citeseer
An international panel of the International Atherosclerosis Society has developed a new set
of recommendations for the management of dyslipidemia. The panel identifies non—high …

[PDF][PDF] Reprint: 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults

NJ Stone, JG Robinson, AH Lichtenstein… - J Am Pharm …, 2013 - Citeseer
Reprint: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce
Atherosclerotic Cardiovascular Risk in Adults Page 1 Stone NJ, et al. 2013 ACC/AHA Blood …

An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia-full report

SM Grundy, H Arai, P Barter, TP Bersot… - Journal of clinical …, 2014 - Elsevier
An international panel of the International Atherosclerosis Society has developed a new set
of recommendations for the management of dyslipidemia. The panel identifies non-high …